image
Healthcare - Drug Manufacturers - General - NYSE - US
$ 746.2
-4.93 %
$ 708 B
Market Cap
80.41
P/E
1. INTRINSIC VALUE

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer.[ Read More ]

The intrinsic value of one LLY stock under the base case scenario is HIDDEN Compared to the current market price of 746 USD, Eli Lilly and Company is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart LLY

image
FINANCIALS
34.1 B REVENUE
19.56%
10.3 B OPERATING INCOME
44.87%
5.24 B NET INCOME
-16.08%
4.24 B OPERATING CASH FLOW
-40.15%
-7.15 B INVESTING CASH FLOW
-119.30%
3.5 B FINANCING CASH FLOW
164.65%
11.4 B REVENUE
1.21%
4.43 B OPERATING INCOME
3.03%
970 M NET INCOME
-67.30%
3.71 B OPERATING CASH FLOW
153.16%
-4 B INVESTING CASH FLOW
-82.14%
211 M FINANCING CASH FLOW
-86.42%
Balance Sheet Decomposition Eli Lilly and Company
image
Current Assets 25.7 B
Cash & Short-Term Investments 2.93 B
Receivables 11.3 B
Other Current Assets 11.5 B
Non-Current Assets 38.3 B
Long-Term Investments 3.05 B
PP&E 12.9 B
Other Non-Current Assets 22.3 B
Current Liabilities 27.3 B
Accounts Payable 2.6 B
Short-Term Debt 6.9 B
Other Current Liabilities 17.8 B
Non-Current Liabilities 25.8 B
Long-Term Debt 18.3 B
Other Non-Current Liabilities 7.53 B
EFFICIENCY
Earnings Waterfall Eli Lilly and Company
image
Revenue 34.1 B
Cost Of Revenue 7.08 B
Gross Profit 27 B
Operating Expenses 16.7 B
Operating Income 10.3 B
Other Expenses 5.08 B
Net Income 5.24 B
RATIOS
79.25% GROSS MARGIN
79.25%
30.26% OPERATING MARGIN
30.26%
15.36% NET MARGIN
15.36%
48.65% ROE
48.65%
8.19% ROA
8.19%
22.93% ROIC
22.93%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Eli Lilly and Company
image
Net Income 5.24 B
Depreciation & Amortization 1.53 B
Capital Expenditures -7.39 B
Stock-Based Compensation 628 M
Change in Working Capital -3.06 B
Others -1.21 B
Free Cash Flow -3.15 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Eli Lilly and Company
image
Wall Street analysts predict an average 1-year price target for LLY of $949 , with forecasts ranging from a low of $535 to a high of $1.15 K.
LLY Lowest Price Target Wall Street Target
535 USD -28.30%
LLY Average Price Target Wall Street Target
949 USD 27.18%
LLY Highest Price Target Wall Street Target
1.15 K USD 54.11%
4. DIVIDEND ANALYSIS
0.15% DIVIDEND YIELD
1.3 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Eli Lilly and Company
image
Sold
0-3 MONTHS
51.6 M USD 2
3-6 MONTHS
1.69 B USD 3
6-9 MONTHS
171 M USD 2
9-12 MONTHS
437 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 week ago
Nov 08, 2024
Sell 723 K USD
Zakrowski Donald A
SVP, Finance, & CAO
- 900
803.38 USD
2 months ago
Sep 03, 2024
Sell 15.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 16185
966.189 USD
2 months ago
Sep 03, 2024
Sell 5.15 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5320
967.283 USD
2 months ago
Sep 03, 2024
Sell 1.55 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1600
968.314 USD
2 months ago
Sep 03, 2024
Sell 949 K USD
LILLY ENDOWMENT INC
10 percent owner
- 979
969.176 USD
2 months ago
Aug 27, 2024
Sell 7.13 M USD
LILLY ENDOWMENT INC
10 percent owner
- 7382
966.378 USD
2 months ago
Aug 27, 2024
Sell 3.84 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3964
967.519 USD
2 months ago
Aug 27, 2024
Sell 1.82 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1882
968.517 USD
2 months ago
Aug 27, 2024
Sell 6.42 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6623
969.557 USD
2 months ago
Aug 27, 2024
Sell 2.23 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2301
970.515 USD
2 months ago
Aug 27, 2024
Sell 2.23 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2300
971.355 USD
2 months ago
Aug 27, 2024
Sell 97.2 K USD
LILLY ENDOWMENT INC
10 percent owner
- 100
972.235 USD
2 months ago
Aug 26, 2024
Sell 712 K USD
Zakrowski Donald A
SVP, Finance, & CAO
- 750
950 USD
2 months ago
Aug 22, 2024
Sell 2.89 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2996
966.282 USD
2 months ago
Aug 22, 2024
Sell 193 K USD
LILLY ENDOWMENT INC
10 percent owner
- 200
967.005 USD
4 months ago
Jul 10, 2024
Sell 23.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 25067
936.895 USD
4 months ago
Jul 10, 2024
Sell 14 M USD
LILLY ENDOWMENT INC
10 percent owner
- 14916
938.028 USD
4 months ago
Jul 10, 2024
Sell 26.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 28486
939.11 USD
4 months ago
Jul 10, 2024
Sell 87.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 92882
939.952 USD
4 months ago
Jul 10, 2024
Sell 27.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 29147
940.868 USD
4 months ago
Jul 10, 2024
Sell 2.07 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2198
941.962 USD
4 months ago
Jul 10, 2024
Sell 4.26 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4519
943.094 USD
4 months ago
Jul 10, 2024
Sell 8.77 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9285
944.062 USD
4 months ago
Jul 10, 2024
Sell 3.31 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3500
944.899 USD
4 months ago
Jul 08, 2024
Sell 8.46 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9241
915.624 USD
4 months ago
Jul 08, 2024
Sell 11.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12899
916.489 USD
4 months ago
Jul 08, 2024
Sell 20.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 22438
917.47 USD
4 months ago
Jul 08, 2024
Sell 17.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 18992
918.353 USD
4 months ago
Jul 08, 2024
Sell 10.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 11390
919.413 USD
4 months ago
Jul 08, 2024
Sell 4.09 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4446
920.373 USD
4 months ago
Jul 08, 2024
Sell 1.43 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1550
921.453 USD
4 months ago
Jul 08, 2024
Sell 4.69 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5088
922.608 USD
4 months ago
Jul 08, 2024
Sell 3.57 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3864
923.7 USD
4 months ago
Jul 08, 2024
Sell 1.47 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1585
924.707 USD
4 months ago
Jul 08, 2024
Sell 1.39 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1500
926.231 USD
4 months ago
Jul 08, 2024
Sell 371 K USD
LILLY ENDOWMENT INC
10 percent owner
- 400
927.3 USD
4 months ago
Jul 08, 2024
Sell 186 K USD
LILLY ENDOWMENT INC
10 percent owner
- 200
928.253 USD
4 months ago
Jul 05, 2024
Sell 46.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 50540
915.144 USD
4 months ago
Jul 05, 2024
Sell 1.68 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1829
916.247 USD
4 months ago
Jul 03, 2024
Sell 7.37 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8048
915.144 USD
4 months ago
Jul 03, 2024
Sell 366 K USD
LILLY ENDOWMENT INC
10 percent owner
- 400
916.213 USD
4 months ago
Jul 03, 2024
Sell 367 K USD
LILLY ENDOWMENT INC
10 percent owner
- 400
917.726 USD
4 months ago
Jul 01, 2024
Sell 49.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 53949
915.171 USD
4 months ago
Jul 01, 2024
Sell 4.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4800
916.295 USD
4 months ago
Jun 28, 2024
Sell 1.32 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1441
915.021 USD
4 months ago
Jun 25, 2024
Sell 51.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 57563
902.272 USD
4 months ago
Jun 25, 2024
Sell 56.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 62127
903.563 USD
4 months ago
Jun 25, 2024
Sell 41.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 46359
904.518 USD
4 months ago
Jun 25, 2024
Sell 3.64 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4019
905.401 USD
4 months ago
Jun 25, 2024
Sell 4.36 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4806
906.4 USD
4 months ago
Jun 25, 2024
Sell 6.14 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6763
907.278 USD
4 months ago
Jun 25, 2024
Sell 5.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5610
908.602 USD
4 months ago
Jun 25, 2024
Sell 775 K USD
LILLY ENDOWMENT INC
10 percent owner
- 853
909.059 USD
4 months ago
Jun 24, 2024
Sell 14.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 16029
902.3 USD
4 months ago
Jun 24, 2024
Sell 1.08 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1200
903.418 USD
4 months ago
Jun 20, 2024
Sell 5.91 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6552
902.253 USD
4 months ago
Jun 20, 2024
Sell 2.64 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2919
903.502 USD
4 months ago
Jun 20, 2024
Sell 181 K USD
LILLY ENDOWMENT INC
10 percent owner
- 200
904.245 USD
5 months ago
Jun 17, 2024
Sell 32.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 36716
882.453 USD
5 months ago
Jun 17, 2024
Sell 19.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 22282
883.434 USD
5 months ago
Jun 17, 2024
Sell 10.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 11820
884.56 USD
5 months ago
Jun 17, 2024
Sell 24.2 M USD
LILLY ENDOWMENT INC
10 percent owner
- 27351
885.575 USD
5 months ago
Jun 17, 2024
Sell 15.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 17513
886.604 USD
5 months ago
Jun 17, 2024
Sell 33.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 38194
887.466 USD
5 months ago
Jun 17, 2024
Sell 16.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 18293
888.517 USD
5 months ago
Jun 17, 2024
Sell 13.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 15342
889.363 USD
5 months ago
Jun 17, 2024
Sell 5.45 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6121
890.503 USD
5 months ago
Jun 17, 2024
Sell 1.16 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1300
891.537 USD
5 months ago
Jun 17, 2024
Sell 41 K USD
LILLY ENDOWMENT INC
10 percent owner
- 46
892.14 USD
5 months ago
Jun 14, 2024
Sell 10.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12363
882.277 USD
5 months ago
Jun 14, 2024
Sell 2.35 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2659
883.377 USD
5 months ago
Jun 10, 2024
Sell 1.96 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2300
851.688 USD
5 months ago
Jun 10, 2024
Sell 341 K USD
LILLY ENDOWMENT INC
10 percent owner
- 400
852.36 USD
5 months ago
Jun 10, 2024
Sell 1.98 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2313
854.212 USD
5 months ago
Jun 10, 2024
Sell 3.28 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3837
855.561 USD
5 months ago
Jun 10, 2024
Sell 5.37 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6267
856.673 USD
5 months ago
Jun 10, 2024
Sell 5.04 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5879
857.668 USD
5 months ago
Jun 10, 2024
Sell 7.59 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8835
858.723 USD
5 months ago
Jun 10, 2024
Sell 7.74 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9001
859.487 USD
5 months ago
Jun 10, 2024
Sell 7.21 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8374
860.713 USD
5 months ago
Jun 10, 2024
Sell 822 K USD
LILLY ENDOWMENT INC
10 percent owner
- 954
861.435 USD
5 months ago
Jun 10, 2024
Sell 3.11 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3600
862.827 USD
5 months ago
Jun 10, 2024
Sell 656 K USD
LILLY ENDOWMENT INC
10 percent owner
- 759
863.814 USD
5 months ago
Jun 10, 2024
Sell 11.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13415
865.061 USD
5 months ago
Jun 10, 2024
Sell 1.54 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1780
865.888 USD
5 months ago
Jun 10, 2024
Sell 2.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3117
867.032 USD
5 months ago
Jun 10, 2024
Sell 2.26 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2600
868.206 USD
5 months ago
Jun 10, 2024
Sell 1.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1500
869.215 USD
5 months ago
Jun 10, 2024
Sell 504 K USD
LILLY ENDOWMENT INC
10 percent owner
- 579
870.13 USD
5 months ago
Jun 07, 2024
Sell 62 M USD
LILLY ENDOWMENT INC
10 percent owner
- 72872
851.291 USD
5 months ago
Jun 07, 2024
Sell 25.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 29973
852.495 USD
5 months ago
Jun 07, 2024
Sell 17.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 20432
853.522 USD
5 months ago
Jun 07, 2024
Sell 8.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9952
854.394 USD
5 months ago
Jun 07, 2024
Sell 4.41 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5150
855.523 USD
5 months ago
Jun 07, 2024
Sell 951 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1111
856.384 USD
5 months ago
Jun 06, 2024
Sell 84.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 100783
836.151 USD
5 months ago
Jun 06, 2024
Sell 17.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 20822
837.507 USD
5 months ago
Jun 06, 2024
Sell 17.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 20634
838.515 USD
5 months ago
Jun 06, 2024
Sell 6.26 M USD
LILLY ENDOWMENT INC
10 percent owner
- 7460
839.456 USD
5 months ago
Jun 06, 2024
Sell 5.75 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6836
840.499 USD
5 months ago
Jun 06, 2024
Sell 4.03 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4790
841.368 USD
5 months ago
Jun 06, 2024
Sell 4.68 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5559
842.669 USD
5 months ago
Jun 06, 2024
Sell 4.35 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5158
843.459 USD
5 months ago
Jun 06, 2024
Sell 3.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4029
844.779 USD
5 months ago
Jun 06, 2024
Sell 2.54 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3000
845.588 USD
5 months ago
Jun 06, 2024
Sell 462 K USD
LILLY ENDOWMENT INC
10 percent owner
- 546
846.336 USD
5 months ago
Jun 05, 2024
Sell 15 M USD
LILLY ENDOWMENT INC
10 percent owner
- 17983
836.14 USD
5 months ago
Jun 05, 2024
Sell 2.01 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2400
837.653 USD
5 months ago
Jun 03, 2024
Sell 2.94 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3582
822.071 USD
5 months ago
Jun 03, 2024
Sell 4.59 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5570
823.712 USD
5 months ago
Jun 03, 2024
Sell 2.31 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2801
824.782 USD
5 months ago
Jun 03, 2024
Sell 4.39 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5313
825.778 USD
5 months ago
Jun 03, 2024
Sell 7.03 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8505
826.852 USD
5 months ago
Jun 03, 2024
Sell 14.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 17251
827.761 USD
5 months ago
Jun 03, 2024
Sell 24.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 29045
828.896 USD
5 months ago
Jun 03, 2024
Sell 33.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 40708
829.756 USD
5 months ago
Jun 03, 2024
Sell 24.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 29541
830.806 USD
5 months ago
Jun 03, 2024
Sell 22.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 27500
831.826 USD
5 months ago
Jun 03, 2024
Sell 10.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12813
832.715 USD
5 months ago
Jun 03, 2024
Sell 3.92 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4700
833.738 USD
5 months ago
Jun 03, 2024
Sell 1.25 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1500
834.813 USD
5 months ago
Jun 03, 2024
Sell 647 K USD
LILLY ENDOWMENT INC
10 percent owner
- 774
835.861 USD
5 months ago
Jun 03, 2024
Sell 753 K USD
LILLY ENDOWMENT INC
10 percent owner
- 900
837.16 USD
5 months ago
Jun 03, 2024
Sell 1.92 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2291
837.996 USD
5 months ago
Jun 03, 2024
Sell 615 K USD
Zakrowski Donald A
SVP, Finance, & CAO
- 750
819.47 USD
5 months ago
Jun 03, 2024
Sell 5.78 M USD
Norton Johna
EVP, Global Quality
- 7056
819.38 USD
5 months ago
May 31, 2024
Sell 17.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 20806
822.04 USD
5 months ago
May 31, 2024
Sell 1.15 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1400
823.219 USD
5 months ago
May 29, 2024
Sell 19.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 24547
809.345 USD
5 months ago
May 29, 2024
Sell 26.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 32980
810.615 USD
5 months ago
May 29, 2024
Sell 44.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 55257
811.512 USD
5 months ago
May 29, 2024
Sell 10.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12635
812.238 USD
5 months ago
May 29, 2024
Sell 2.05 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2516
813.573 USD
5 months ago
May 29, 2024
Sell 1.83 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2250
814.46 USD
5 months ago
May 29, 2024
Sell 163 K USD
LILLY ENDOWMENT INC
10 percent owner
- 200
815.35 USD
5 months ago
May 28, 2024
Sell 1.66 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2052
809 USD
5 months ago
May 24, 2024
Sell 74.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 92563
809.211 USD
5 months ago
May 23, 2024
Sell 4.88 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6061
804.349 USD
5 months ago
May 23, 2024
Sell 3.94 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4886
805.586 USD
5 months ago
May 23, 2024
Sell 2.82 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3491
806.675 USD
5 months ago
May 23, 2024
Sell 3.16 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3917
807.483 USD
5 months ago
May 23, 2024
Sell 2.08 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2567
808.657 USD
5 months ago
May 23, 2024
Sell 5.52 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6813
809.66 USD
5 months ago
May 23, 2024
Sell 1.98 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2448
810.711 USD
5 months ago
May 23, 2024
Sell 4.07 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5016
811.814 USD
5 months ago
May 23, 2024
Sell 3.77 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4643
812.707 USD
5 months ago
May 23, 2024
Sell 3.55 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4356
813.84 USD
5 months ago
May 23, 2024
Sell 1.56 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1910
814.793 USD
5 months ago
May 23, 2024
Sell 827 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1013
816.007 USD
5 months ago
May 23, 2024
Sell 1.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2076
816.82 USD
5 months ago
May 23, 2024
Sell 661 K USD
LILLY ENDOWMENT INC
10 percent owner
- 808
817.859 USD
5 months ago
May 23, 2024
Sell 558 K USD
LILLY ENDOWMENT INC
10 percent owner
- 681
818.821 USD
5 months ago
May 23, 2024
Sell 66.5 K USD
LILLY ENDOWMENT INC
10 percent owner
- 81
820.5 USD
5 months ago
May 22, 2024
Sell 10.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12974
804.184 USD
5 months ago
May 21, 2024
Sell 78.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 97907
804.317 USD
5 months ago
May 21, 2024
Sell 31.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 39536
805.389 USD
5 months ago
May 21, 2024
Sell 20.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 25891
806.432 USD
5 months ago
May 21, 2024
Sell 4.15 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5145
807.368 USD
5 months ago
May 21, 2024
Sell 4.94 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6105
808.534 USD
5 months ago
May 21, 2024
Sell 3.63 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4481
809.449 USD
5 months ago
May 21, 2024
Sell 3.79 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4680
810.384 USD
5 months ago
May 21, 2024
Sell 1.53 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1889
812.274 USD
5 months ago
May 21, 2024
Sell 508 K USD
LILLY ENDOWMENT INC
10 percent owner
- 625
812.971 USD
8 months ago
Mar 11, 2024
Sell 565 K USD
Zakrowski Donald A
SVP, Finance, & CAO
- 750
753.6 USD
9 months ago
Feb 16, 2024
Sell 841 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1100
764.288 USD
9 months ago
Feb 16, 2024
Sell 2.16 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2817
765.427 USD
9 months ago
Feb 16, 2024
Sell 2.66 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3473
766.313 USD
9 months ago
Feb 16, 2024
Sell 4.55 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5934
767.141 USD
9 months ago
Feb 16, 2024
Sell 3.62 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4709
768.409 USD
9 months ago
Feb 16, 2024
Sell 923 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1200
769.196 USD
9 months ago
Feb 16, 2024
Sell 12.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 16800
770.054 USD
9 months ago
Feb 16, 2024
Sell 1.39 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1800
771.259 USD
9 months ago
Feb 16, 2024
Sell 1.16 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1500
772.475 USD
9 months ago
Feb 16, 2024
Sell 1.55 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2000
773.593 USD
9 months ago
Feb 16, 2024
Sell 3.06 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3945
774.554 USD
9 months ago
Feb 16, 2024
Sell 2.49 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3205
775.405 USD
9 months ago
Feb 16, 2024
Sell 1.58 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2035
776.553 USD
9 months ago
Feb 16, 2024
Sell 1.32 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1700
777.459 USD
9 months ago
Feb 16, 2024
Sell 701 K USD
LILLY ENDOWMENT INC
10 percent owner
- 900
778.76 USD
9 months ago
Feb 16, 2024
Sell 919 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1178
780.148 USD
9 months ago
Feb 16, 2024
Sell 1.66 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2122
781.177 USD
9 months ago
Feb 16, 2024
Sell 12.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 15436
782.136 USD
9 months ago
Feb 16, 2024
Sell 7.17 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9150
783.398 USD
9 months ago
Feb 16, 2024
Sell 9.63 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12275
784.283 USD
9 months ago
Feb 16, 2024
Sell 19.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 25134
785.246 USD
9 months ago
Feb 16, 2024
Sell 6.85 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8710
786.265 USD
9 months ago
Feb 16, 2024
Sell 10.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12775
787.425 USD
9 months ago
Feb 16, 2024
Sell 10.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13487
788.286 USD
9 months ago
Feb 16, 2024
Sell 7.98 M USD
LILLY ENDOWMENT INC
10 percent owner
- 10110
789.291 USD
9 months ago
Feb 16, 2024
Sell 2.85 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3603
790.231 USD
9 months ago
Feb 16, 2024
Sell 1.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1386
791.192 USD
9 months ago
Feb 16, 2024
Sell 475 K USD
LILLY ENDOWMENT INC
10 percent owner
- 600
792.053 USD
9 months ago
Feb 16, 2024
Sell 476 K USD
LILLY ENDOWMENT INC
10 percent owner
- 600
793.078 USD
9 months ago
Feb 15, 2024
Sell 31.2 M USD
LILLY ENDOWMENT INC
10 percent owner
- 41053
760.191 USD
9 months ago
Feb 15, 2024
Sell 5.99 M USD
LILLY ENDOWMENT INC
10 percent owner
- 7863
761.558 USD
9 months ago
Feb 15, 2024
Sell 1.07 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1400
762.261 USD
9 months ago
Feb 09, 2024
Sell 123 M USD
LILLY ENDOWMENT INC
10 percent owner
- 165545
740.266 USD
9 months ago
Feb 09, 2024
Sell 22.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 30253
741.412 USD
9 months ago
Feb 09, 2024
Sell 3.56 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4792
742.217 USD
9 months ago
Feb 09, 2024
Sell 1.12 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1500
743.576 USD
9 months ago
Feb 09, 2024
Sell 1.39 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1867
744.529 USD
9 months ago
Feb 09, 2024
Sell 1.71 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2300
745.24 USD
9 months ago
Feb 08, 2024
Sell 6.47 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8743
740.059 USD
9 months ago
Jan 31, 2024
Sell 22.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 35506
645.282 USD
9 months ago
Jan 31, 2024
Sell 5.93 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9169
646.41 USD
9 months ago
Jan 31, 2024
Sell 5.63 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8696
647.532 USD
9 months ago
Jan 31, 2024
Sell 4.82 M USD
LILLY ENDOWMENT INC
10 percent owner
- 7424
648.598 USD
9 months ago
Jan 31, 2024
Sell 3.2 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4931
649.803 USD
9 months ago
Jan 31, 2024
Sell 530 K USD
LILLY ENDOWMENT INC
10 percent owner
- 815
650.729 USD
9 months ago
Jan 31, 2024
Sell 586 K USD
LILLY ENDOWMENT INC
10 percent owner
- 900
651.56 USD
9 months ago
Jan 31, 2024
Sell 1.24 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1900
654.252 USD
9 months ago
Jan 31, 2024
Sell 1.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2750
655.265 USD
9 months ago
Jan 31, 2024
Sell 1.12 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1700
656.302 USD
9 months ago
Jan 31, 2024
Sell 394 K USD
LILLY ENDOWMENT INC
10 percent owner
- 600
657.398 USD
9 months ago
Jan 31, 2024
Sell 1.12 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1700
658.651 USD
9 months ago
Jan 31, 2024
Sell 526 K USD
LILLY ENDOWMENT INC
10 percent owner
- 797
659.64 USD
9 months ago
Jan 31, 2024
Sell 651 K USD
LILLY ENDOWMENT INC
10 percent owner
- 985
661.088 USD
9 months ago
Jan 31, 2024
Sell 132 K USD
LILLY ENDOWMENT INC
10 percent owner
- 200
661.63 USD
9 months ago
Jan 31, 2024
Sell 331 K USD
LILLY ENDOWMENT INC
10 percent owner
- 500
662.808 USD
9 months ago
Jan 30, 2024
Sell 44.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 69370
645.113 USD
9 months ago
Jan 30, 2024
Sell 4.42 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6845
646.269 USD
9 months ago
Jan 29, 2024
Sell 34.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 54032
645.07 USD
10 months ago
Jan 16, 2024
Sell 697 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1080
645.545 USD
10 months ago
Jan 16, 2024
Sell 64.6 K USD
LILLY ENDOWMENT INC
10 percent owner
- 100
646.17 USD
10 months ago
Jan 11, 2024
Sell 945 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1500
630.244 USD
10 months ago
Jan 11, 2024
Sell 758 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1200
631.672 USD
10 months ago
Jan 11, 2024
Sell 1.09 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1724
632.839 USD
10 months ago
Jan 11, 2024
Sell 761 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1200
633.91 USD
10 months ago
Jan 11, 2024
Sell 1.78 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2799
635.053 USD
10 months ago
Jan 11, 2024
Sell 1.73 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2721
635.944 USD
10 months ago
Jan 11, 2024
Sell 637 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1000
636.864 USD
10 months ago
Jan 11, 2024
Sell 128 K USD
LILLY ENDOWMENT INC
10 percent owner
- 200
639.13 USD
10 months ago
Jan 10, 2024
Sell 81.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 128627
630.19 USD
10 months ago
Jan 10, 2024
Sell 13.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 21503
631.378 USD
10 months ago
Jan 10, 2024
Sell 5.75 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9098
632.171 USD
10 months ago
Jan 10, 2024
Sell 508 K USD
LILLY ENDOWMENT INC
10 percent owner
- 802
633.515 USD
10 months ago
Jan 10, 2024
Sell 1.27 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2000
634.817 USD
10 months ago
Jan 10, 2024
Sell 572 K USD
LILLY ENDOWMENT INC
10 percent owner
- 900
635.742 USD
10 months ago
Jan 10, 2024
Sell 509 K USD
LILLY ENDOWMENT INC
10 percent owner
- 800
636.288 USD
10 months ago
Jan 09, 2024
Sell 6.85 M USD
LILLY ENDOWMENT INC
10 percent owner
- 10873
630.389 USD
10 months ago
Jan 09, 2024
Sell 3.54 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5608
631.715 USD
10 months ago
Jan 09, 2024
Sell 9.21 M USD
LILLY ENDOWMENT INC
10 percent owner
- 14566
632.521 USD
10 months ago
Jan 09, 2024
Sell 2.21 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3491
633.41 USD
10 months ago
Jan 04, 2024
Sell 8.63 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13688
630.238 USD
10 months ago
Jan 04, 2024
Sell 442 K USD
LILLY ENDOWMENT INC
10 percent owner
- 700
631.068 USD
1 year ago
Nov 06, 2023
Sell 383 K USD
Zakrowski Donald A
SVP, Finance, & CAO
- 670
571.1 USD
1 year ago
Oct 11, 2023
Sell 22.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 37835
603.243 USD
1 year ago
Oct 11, 2023
Sell 18 M USD
LILLY ENDOWMENT INC
10 percent owner
- 29842
604.397 USD
1 year ago
Oct 11, 2023
Sell 44.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 74203
605.412 USD
1 year ago
Oct 11, 2023
Sell 31.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 51998
606.747 USD
1 year ago
Oct 11, 2023
Sell 12.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 21122
607.743 USD
1 year ago
Sep 12, 2023
Sell 678 K USD
Weems Alonzo
EVP, ERM & CECO
- 1148
590.98 USD
1 year ago
Sep 07, 2023
Sell 2.37 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4200
565.136 USD
1 year ago
Sep 07, 2023
Sell 4.38 M USD
LILLY ENDOWMENT INC
10 percent owner
- 7732
566.063 USD
1 year ago
Sep 07, 2023
Sell 4.19 M USD
LILLY ENDOWMENT INC
10 percent owner
- 7382
567.185 USD
1 year ago
Sep 07, 2023
Sell 8.51 M USD
LILLY ENDOWMENT INC
10 percent owner
- 14978
568.093 USD
1 year ago
Sep 07, 2023
Sell 8.68 M USD
LILLY ENDOWMENT INC
10 percent owner
- 15258
568.894 USD
1 year ago
Sep 07, 2023
Sell 5.94 M USD
LILLY ENDOWMENT INC
10 percent owner
- 10412
570.047 USD
1 year ago
Sep 07, 2023
Sell 15.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 27849
571.656 USD
1 year ago
Sep 07, 2023
Sell 34.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 60926
572.357 USD
1 year ago
Sep 07, 2023
Sell 26.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 46428
573.335 USD
1 year ago
Sep 07, 2023
Sell 6.51 M USD
LILLY ENDOWMENT INC
10 percent owner
- 11335
574.28 USD
1 year ago
Sep 07, 2023
Sell 2.01 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3500
575.372 USD
1 year ago
Aug 31, 2023
Sell 18.2 M USD
LILLY ENDOWMENT INC
10 percent owner
- 32894
554.375 USD
1 year ago
Aug 31, 2023
Sell 4.61 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8306
555.351 USD
1 year ago
Aug 31, 2023
Sell 2.47 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4441
556.581 USD
1 year ago
Aug 31, 2023
Sell 501 K USD
LILLY ENDOWMENT INC
10 percent owner
- 900
557.193 USD
1 year ago
Aug 30, 2023
Sell 1.01 M USD
LILLY ENDOWMENT INC
10 percent owner
- 1825
554.167 USD
1 year ago
Aug 30, 2023
Sell 1.67 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3000
555.282 USD
1 year ago
Aug 30, 2023
Sell 254 K USD
LILLY ENDOWMENT INC
10 percent owner
- 456
556.13 USD
1 year ago
Aug 30, 2023
Sell 502 K USD
LILLY ENDOWMENT INC
10 percent owner
- 900
557.357 USD
1 year ago
Aug 29, 2023
Sell 15.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 28447
554.081 USD
1 year ago
Aug 29, 2023
Sell 167 K USD
LILLY ENDOWMENT INC
10 percent owner
- 300
555.85 USD
1 year ago
Aug 28, 2023
Sell 20.6 B USD
LILLY ENDOWMENT INC
10 percent owner
- 37160
554101 USD
1 year ago
Aug 28, 2023
Sell 278 K USD
LILLY ENDOWMENT INC
10 percent owner
- 500
555.54 USD
1 year ago
Aug 25, 2023
Sell 30.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 54745
554.217 USD
1 year ago
Aug 25, 2023
Sell 4.74 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8527
555.39 USD
1 year ago
Aug 25, 2023
Sell 167 K USD
LILLY ENDOWMENT INC
10 percent owner
- 300
556.06 USD
1 year ago
Aug 24, 2023
Sell 9.03 M USD
LILLY ENDOWMENT INC
10 percent owner
- 16292
554.325 USD
1 year ago
Aug 24, 2023
Sell 778 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1400
555.753 USD
1 year ago
Aug 24, 2023
Sell 1.84 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3300
556.337 USD
1 year ago
Aug 23, 2023
Sell 726 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1307
555.6882 USD
1 year ago
Aug 21, 2023
Sell 328 K USD
Zakrowski Donald A
SVP, Finance, & CAO
- 600
546.51 USD
1 year ago
Aug 15, 2023
Sell 4.48 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8323
538.322 USD
1 year ago
Aug 15, 2023
Sell 838 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1554
539.531 USD
1 year ago
Aug 15, 2023
Sell 270 K USD
LILLY ENDOWMENT INC
10 percent owner
- 500
540.736 USD
1 year ago
Aug 15, 2023
Sell 811 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1497
541.946 USD
1 year ago
Aug 15, 2023
Sell 1.14 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2100
543.078 USD
1 year ago
Aug 15, 2023
Sell 3.93 M USD
LILLY ENDOWMENT INC
10 percent owner
- 7223
544.009 USD
1 year ago
Aug 15, 2023
Sell 6.92 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12698
544.903 USD
1 year ago
Aug 15, 2023
Sell 6.75 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12366
545.979 USD
1 year ago
Aug 15, 2023
Sell 2.17 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3961
546.732 USD
1 year ago
Aug 14, 2023
Sell 54.1 M USD
LILLY ENDOWMENT INC
10 percent owner
- 100500
538.264 USD
1 year ago
Aug 14, 2023
Sell 16.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 30918
539.446 USD
1 year ago
Aug 14, 2023
Sell 7.34 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13571
540.652 USD
1 year ago
Aug 14, 2023
Sell 9.17 M USD
LILLY ENDOWMENT INC
10 percent owner
- 16933
541.528 USD
1 year ago
Aug 14, 2023
Sell 1.55 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2856
542.1 USD
1 year ago
Aug 11, 2023
Sell 34.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 65457
528.192 USD
1 year ago
Aug 11, 2023
Sell 6.98 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13181
529.399 USD
1 year ago
Aug 11, 2023
Sell 2.02 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3817
530.327 USD
1 year ago
Aug 11, 2023
Sell 310 K USD
LILLY ENDOWMENT INC
10 percent owner
- 584
531.335 USD
1 year ago
Aug 10, 2023
Sell 1.58 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3000
528.135 USD
1 year ago
Aug 09, 2023
Sell 42.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 81132
528.228 USD
1 year ago
Aug 09, 2023
Sell 14.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 28158
529.535 USD
1 year ago
Aug 09, 2023
Sell 5.24 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9871
530.541 USD
1 year ago
Aug 09, 2023
Sell 2.44 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4600
531.319 USD
1 year ago
Aug 09, 2023
Sell 106 K USD
LILLY ENDOWMENT INC
10 percent owner
- 200
532.18 USD
1 year ago
Aug 08, 2023
Sell 654 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1299
503.826 USD
1 year ago
Aug 08, 2023
Sell 505 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1000
504.915 USD
1 year ago
Aug 08, 2023
Sell 1.11 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2200
505.905 USD
1 year ago
Aug 08, 2023
Sell 966 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1900
508.59 USD
1 year ago
Aug 08, 2023
Sell 698 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1364
511.577 USD
1 year ago
Aug 08, 2023
Sell 461 K USD
LILLY ENDOWMENT INC
10 percent owner
- 900
512.582 USD
1 year ago
Aug 08, 2023
Sell 3.04 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5920
514.117 USD
1 year ago
Aug 08, 2023
Sell 5.92 M USD
LILLY ENDOWMENT INC
10 percent owner
- 11502
514.78 USD
1 year ago
Aug 08, 2023
Sell 2.58 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5000
515.973 USD
1 year ago
Aug 08, 2023
Sell 2.64 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5103
516.997 USD
1 year ago
Aug 08, 2023
Sell 3.47 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6700
517.893 USD
1 year ago
Aug 08, 2023
Sell 7.18 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13842
518.992 USD
1 year ago
Aug 08, 2023
Sell 3.54 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6813
519.811 USD
1 year ago
Aug 08, 2023
Sell 8.69 M USD
LILLY ENDOWMENT INC
10 percent owner
- 16672
521.086 USD
1 year ago
Aug 08, 2023
Sell 5.83 M USD
LILLY ENDOWMENT INC
10 percent owner
- 11173
521.855 USD
1 year ago
Aug 08, 2023
Sell 5.37 M USD
LILLY ENDOWMENT INC
10 percent owner
- 10264
522.989 USD
1 year ago
Aug 08, 2023
Sell 4.67 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8903
524.066 USD
1 year ago
Aug 08, 2023
Sell 1.78 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3388
524.756 USD
1 year ago
Aug 08, 2023
Sell 3.18 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6049
526.279 USD
1 year ago
Aug 08, 2023
Sell 11.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 21450
527.171 USD
1 year ago
Aug 08, 2023
Sell 5.39 M USD
LILLY ENDOWMENT INC
10 percent owner
- 10206
528.32 USD
1 year ago
Aug 08, 2023
Sell 3.29 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6211
529.216 USD
1 year ago
Aug 08, 2023
Sell 8.04 M USD
LILLY ENDOWMENT INC
10 percent owner
- 15158
530.199 USD
1 year ago
Aug 08, 2023
Sell 4.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8478
531.112 USD
1 year ago
Aug 08, 2023
Sell 3.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6200
532.178 USD
1 year ago
Aug 08, 2023
Sell 2.93 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5493
534.084 USD
1 year ago
Aug 08, 2023
Sell 3.54 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6619
534.887 USD
1 year ago
Aug 08, 2023
Sell 1.77 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3301
535.85 USD
1 year ago
Aug 08, 2023
Sell 699 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1301
536.949 USD
1 year ago
Jul 21, 2023
Sell 276 K USD
LILLY ENDOWMENT INC
10 percent owner
- 591
466.621 USD
1 year ago
Jun 30, 2023
Sell 5.7 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12244
465.515 USD
1 year ago
Jun 30, 2023
Sell 14 M USD
LILLY ENDOWMENT INC
10 percent owner
- 29938
466.572 USD
1 year ago
Jun 30, 2023
Sell 27.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 58847
467.561 USD
1 year ago
Jun 30, 2023
Sell 25.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 54269
468.408 USD
1 year ago
Jun 30, 2023
Sell 4.14 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8827
469.219 USD
1 year ago
Jun 29, 2023
Sell 20.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 44115
465.083 USD
1 year ago
Jun 28, 2023
Sell 4.97 M USD
LILLY ENDOWMENT INC
10 percent owner
- 10685
465.322 USD
1 year ago
Jun 28, 2023
Sell 501 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1075
466.235 USD
1 year ago
Jun 22, 2023
Sell 2.19 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4801
455.442 USD
1 year ago
Jun 22, 2023
Sell 2.36 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5163
456.595 USD
1 year ago
Jun 22, 2023
Sell 9.21 M USD
LILLY ENDOWMENT INC
10 percent owner
- 20132
457.647 USD
1 year ago
Jun 22, 2023
Sell 2.96 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6455
458.513 USD
1 year ago
Jun 22, 2023
Sell 14.6 M USD
LILLY ENDOWMENT INC
10 percent owner
- 31803
459.721 USD
1 year ago
Jun 22, 2023
Sell 12.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 26924
460.439 USD
1 year ago
Jun 22, 2023
Sell 5.28 M USD
LILLY ENDOWMENT INC
10 percent owner
- 11444
461.425 USD
1 year ago
Jun 22, 2023
Sell 139 K USD
LILLY ENDOWMENT INC
10 percent owner
- 300
462.107 USD
1 year ago
Jun 21, 2023
Sell 13.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 29595
454.079 USD
1 year ago
Jun 21, 2023
Sell 846 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1859
455 USD
1 year ago
Jun 20, 2023
Sell 15.5 M USD
LILLY ENDOWMENT INC
10 percent owner
- 34156
454.08 USD
1 year ago
Jun 16, 2023
Sell 2.59 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5700
454.339 USD
1 year ago
Jun 16, 2023
Sell 7.85 M USD
LILLY ENDOWMENT INC
10 percent owner
- 17231
455.761 USD
1 year ago
Jun 16, 2023
Sell 951 K USD
LILLY ENDOWMENT INC
10 percent owner
- 2084
456.498 USD
1 year ago
Jun 15, 2023
Sell 12.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 27210
454.141 USD
1 year ago
Jun 15, 2023
Sell 65.1 K USD
LILLY ENDOWMENT INC
10 percent owner
- 143
455.043 USD
1 year ago
Jun 14, 2023
Sell 732 K USD
Norton Johna
EVP, Global Quality
- 1647
444.29 USD
1 year ago
Jun 15, 2023
Sell 738 K USD
Norton Johna
EVP, Global Quality
- 1647
448 USD
1 year ago
Jun 01, 2023
Sell 2.58 M USD
Jonsson Patrik
EVP&Pres, LLY Imm, LLY USA&CCO
- 6000
429.46 USD
1 year ago
May 19, 2023
Sell 72.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 163571
442.303 USD
1 year ago
May 19, 2023
Sell 7.38 M USD
LILLY ENDOWMENT INC
10 percent owner
- 16655
443.354 USD
1 year ago
May 19, 2023
Sell 3.01 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6767
444.404 USD
1 year ago
May 19, 2023
Sell 1.17 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2628
445.501 USD
1 year ago
May 19, 2023
Sell 1.98 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4433
446.648 USD
1 year ago
May 19, 2023
Sell 134 K USD
LILLY ENDOWMENT INC
10 percent owner
- 300
447.29 USD
1 year ago
May 15, 2023
Sell 261 K USD
Zakrowski Donald A
SVP, Finance, & CAO
- 600
435.29 USD
1 year ago
May 12, 2023
Sell 5.61 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12685
442.245 USD
1 year ago
May 12, 2023
Sell 2.38 M USD
LILLY ENDOWMENT INC
10 percent owner
- 5359
443.222 USD
1 year ago
May 12, 2023
Sell 1.16 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2602
444.401 USD
1 year ago
May 03, 2023
Sell 166 K USD
LILLY ENDOWMENT INC
10 percent owner
- 400
415.715 USD
1 year ago
May 03, 2023
Sell 1.15 M USD
LILLY ENDOWMENT INC
10 percent owner
- 2750
417.126 USD
1 year ago
May 03, 2023
Sell 1.34 M USD
LILLY ENDOWMENT INC
10 percent owner
- 3200
418.548 USD
1 year ago
May 03, 2023
Sell 2.69 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6400
419.77 USD
1 year ago
May 03, 2023
Sell 3.88 M USD
LILLY ENDOWMENT INC
10 percent owner
- 9226
420.604 USD
1 year ago
May 03, 2023
Sell 8.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 19684
421.65 USD
1 year ago
May 03, 2023
Sell 8.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 19630
422.662 USD
1 year ago
May 03, 2023
Sell 5.44 M USD
LILLY ENDOWMENT INC
10 percent owner
- 12829
423.685 USD
1 year ago
May 03, 2023
Sell 2.65 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6248
424.424 USD
1 year ago
May 03, 2023
Sell 1.77 M USD
LILLY ENDOWMENT INC
10 percent owner
- 4147
425.77 USD
1 year ago
May 03, 2023
Sell 810 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1900
426.506 USD
1 year ago
May 03, 2023
Sell 2.59 M USD
LILLY ENDOWMENT INC
10 percent owner
- 6050
427.841 USD
1 year ago
May 03, 2023
Sell 6.22 M USD
LILLY ENDOWMENT INC
10 percent owner
- 14500
428.692 USD
1 year ago
May 03, 2023
Sell 7.58 M USD
LILLY ENDOWMENT INC
10 percent owner
- 17648
429.72 USD
1 year ago
May 03, 2023
Sell 13.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 30817
430.725 USD
1 year ago
May 03, 2023
Sell 5.83 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13507
431.856 USD
1 year ago
May 03, 2023
Sell 3.4 M USD
LILLY ENDOWMENT INC
10 percent owner
- 7866
432.728 USD
1 year ago
May 03, 2023
Sell 650 K USD
LILLY ENDOWMENT INC
10 percent owner
- 1500
433.561 USD
1 year ago
May 02, 2023
Sell 4.23 M USD
LILLY ENDOWMENT INC
10 percent owner
- 10353
408.72 USD
1 year ago
May 02, 2023
Sell 7.18 M USD
LILLY ENDOWMENT INC
10 percent owner
- 17513
409.709 USD
1 year ago
May 02, 2023
Sell 5.68 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13832
410.561 USD
1 year ago
Apr 28, 2023
Sell 7.32 M USD
LILLY ENDOWMENT INC
10 percent owner
- 18515
395.361 USD
1 year ago
Apr 28, 2023
Sell 25.8 M USD
LILLY ENDOWMENT INC
10 percent owner
- 64998
396.588 USD
1 year ago
Apr 28, 2023
Sell 15.2 M USD
LILLY ENDOWMENT INC
10 percent owner
- 38118
397.563 USD
1 year ago
Apr 28, 2023
Sell 12.3 M USD
LILLY ENDOWMENT INC
10 percent owner
- 30820
398.499 USD
1 year ago
Apr 28, 2023
Sell 5.55 M USD
LILLY ENDOWMENT INC
10 percent owner
- 13899
399.357 USD
1 year ago
Apr 28, 2023
Sell 3.53 M USD
LILLY ENDOWMENT INC
10 percent owner
- 8803
400.756 USD
1 year ago
Apr 28, 2023
Sell 12.9 M USD
LILLY ENDOWMENT INC
10 percent owner
- 32167
401.684 USD
1 year ago
Apr 28, 2023
Sell 4.74 M USD
LILLY ENDOWMENT INC
10 percent owner
- 11765
402.576 USD
7. News
Lilly's tirzepatide reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction (HFpEF) and obesity In a first-of-its-kind study, tirzepatide also alleviated heart failure symptoms and physical limitations Patients on tirzepatide experienced improved exercise capacity, greater weight loss and reduced systemic inflammation Lilly has initiated submissions for tirzepatide for the treatment of HFpEF and obesity to global regulatory agencies INDIANAPOLIS , Nov. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from the SUMMIT Phase 3 trial showing tirzepatide significantly reduced the risk of worsening heart failure events in adults with heart failure with preserved ejection fraction (HFpEF) and obesity. Patients treated with tirzepatide also experienced notable improvements in heart failure symptoms and physical limitations. prnewswire.com - 23 hours ago
As Drug Maker Stocks Fall, Pressure Builds On PhRMA To Derail RFK, Jr. Stocks of major drug makers and biotech companies tumbled in trading late this week after President-elect Donald Trump announced that he wants vaccine skeptic Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services. forbes.com - 1 day ago
Three-Stock Lunch: Eli Lilly, Transdigm, & Nvidia Lee Munson, president and CIO at Portfolio Wealth Advisors, joins CNBC's ‘Power Lunch' to discuss outlooks on three stocks: Eli Lilly, Transdigm, and Nvidia. youtube.com - 1 day ago
Vaccine Maker Stocks Slump After RFK Jr. Nominated as HHS Head In the 2024 presidential election's latest impact on the stock markets, shares of several vaccine makers were down Friday morning following the nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services. investopedia.com - 1 day ago
Lilly Sues U.S. to Change Hospital Drug Discount Payments The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain hospitals. wsj.com - 1 day ago
Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program Eli Lilly (LLY) became the second drugmaker in recent days to sue the U.S. government for rejecting their proposed changes to a program that requires selling discounted drugs to certain medical facilities. investopedia.com - 2 days ago
Lilly sues US agency over blocking of drug-rebate program Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking the company's plan to change the way it offers drug discounts to hospitals. reuters.com - 2 days ago
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030 Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 515.88% and currently trading at $814.25. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years, Eli Lilly went from a $100 billion market capitalization to $740 billion today, which also makes it a potential stock split stock. However, as investors, we care about the stock price years down the line and what Eli Lilly will do in the next 3 to 5 years and beyond. That is why 24/7 Wall Street looks at projected revenue and net income to give you our best estimate of future stock prices from 2025 to 2030. Other “experts” look at past growth rates and assign future stock prices to those past numbers. However, we will walk you through our assumptions and give you the key drivers we see propelling Eli Lilly’s stock in the future. Recent Eli Lilly Stock Updates and News 11/14/2024 Eli Lilly’s weight-loss drug, tirzepatide, has shown promising results in preventing diabetes. After three years of weekly injections, nearly 99% of patients remained diabetes-free. This suggests that for every nine patients treated with tirzepatide, one new case of diabetes could be prevented. 11/12/2024 Eli Lilly’s CEO, Dave Ricks, has been named the recipient of the 2024 August M. Watanabe Life Sciences Champion of the Year Award by BioCrossroads. Under Ricks’ leadership, the company has invested billions of dollars in research and development to address critical health challenges, particularly in areas like oncology, obesity, immunology, and neurodegenerative diseases. 11/11/2024 Susan McGowan, a 58-year-old nurse from Scotland, tragically passed away after taking two doses of tirzepatide, a weight-loss drug manufactured by Eli Lilly. McGowan experienced multiple organ failure, pancreatitis, and septic shock a few days after taking the medication. This is believed to be the first such death in the U.K. officially linked to the medication. 11/8/2024 There is a strong bullish sentiment surrounding Eli Lilly, as seen by the increase in call option trading volume. This surge, particularly in the 820 and 830 strike calls expiring today, suggests that traders are anticipating a potential upside in the stock price. 11/7/2024 After a six-day losing streak, Eli Lilly’s stock is finally rebounding today. While the stock is still down 14% over the past month, it’s still outperforming the broader market, with a year-to-date gain of over 35% compared to the S&P 500’s 24%. 11/5/2024 Eli Lilly has announced that the company will present data from studies of Jaypirca (pirtobrutinib) at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego. The meeting and exposition will be held from December 7th through the 10th. 11/4/2024 Deutsche Bank analyst James Shin has lowered his price target slightly for Eli Lilly, reducing it from $1,025 to $1,015. However, he maintains a “Buy” rating on the stock. 10/31/2024 Eli Lilly released its quarterly earnings report, showcasing strong growth in Q3 and a total revenue rising 42% year-over-year. 10/29/2024 Eli Lilly has received approval to start selling its weight loss drug, Mounjaro, in Hong Kong as early as the end of this year. 10/28/2024 Eli Lilly will release its third-quarter results this Wednesday. Investors are keen to see how the company has performed, particularly regarding Mounjtaro and Zepbound. Analysts expect Eli Lilly to report $12.1 billion in sales and $1.45 in adjusted earnings per share for the quarter. 10/25/2024 Eli Lilly announced positive results from its Phase 3b study of Ebglyss, which focused on patients with moderate-to-severe atopic dermatitis. Patients had been previously treated with Dupixent with little success. However, the results of this latest Ebglyss study show that it was effective in improving skin and itch symptoms, particularly in challenging areas like the face and hands. 10/24/2024 Britain’s National Health Service (NHS) has announced that it will not cover Eli Lilly’s new Alzheimer’s drug, donanemab. Initially, the NHS was expected to approve the drug this week, but instead has decided that it’s too expensive for patients to use. Eli Lilly’s Recent Stock Success How did Eli Lilly’s stock price soar so much in the past few years? Let’s take a look at the numbers: Share Price Revenues* Net Income* 2016 $80.36 $21.22 $2.74 2017 $77.55 $19.94 ($0.21) 2018 $122.13 $21.49 $3.23 2019 $140.83 $22.32 $8.32 2020 $206.46 $24.54 $6.19 2021 $238.31 $28.32 $5.58 2022 329.07 $28.54 $6.25 2023 $745.91 $34.12 $5.24 *Revenue and Net Income in Billions Since 2016, Eli Lilly’s revenue grew by 60% but income grew by 91%. Typically you wouldn’t expect a company growing at its top line by 7% annually to see an 828% increase in share price, however, investor sentiment for the next line of drugs front ran the stock price. For example, in 2016 Eli Lilly was trading 13 times the trailing 12 months earnings and the market has increased its valuation each year and currently trades at a 125 times earnings multiple. This raises the valid question, is Eli Lilly overvalued or will future revenues make up for the expensive valuation? 3 Key Drivers of Eli Lilly Stock Innovated Drug Pipeline: The current drug pipeline is loaded with several very high-potential drugs in development. Mounjaro, Zepbound, and Jardiance in the cardiometabolic category, Taltz in immunology, and Verzenio in oncology are the future of Eli Lilly’s growth. While the aforementioned are the safer bets, the company has a handful of other drugs that could hold blockbuster potential. Strategic Acquisitions: The acquisition of Morphic, with its promising drug candidate MORF-057, is a testament to Lilly’s strategic vision. This drug, if successful in late-stage trials, could become a major success in the treatment of inflammatory bowel disease (IBD). Lilly’s focus on acquiring mid-sized companies (13 since 2020) with promising pipelines has bolstered its own research and development efforts, positioning it well for future growth. Operational Efficiency: With a sound balance sheet, Eli Lilly should continue to improve operational efficiency and manage costs to have net income growth rates above revenue growth. Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 26.50% higher than today’s price of $814.25. Of the 26 analysts covering Eli Lilly stock, the current rating is 1.67 or “Outperform” with 1-year price targets as high as $1,100 and as low as $540.00. 24/7 Wall Street sets its 1-year price target at $1,040. Taking a look at the sum of its parts, we see Eli Lilly’s vertices valued as follows: Endocrinology $735/ share Oncology $122/ Share Cardiovascular $4/ Share Neuroscience $16/ Share Immunology $38/ Share Others and Pipeline $110/ Share Cash $17/ Share Eli Lilly’s Share Price Estimates 2025-2030 Valuing Eli Lilly’s stock price for the coming years, we will take a look at expected revenue and net income and give our best estimate of the market value of the company by assigning a price-to-earnings multiple. Revenue Net Income EPS 2025 $52.8 $17.29 19.11 2026 $62.5 $22.49 25.03 2027 $70.87 $27.12 30.39 2028 $80.68 $32.2 25.97 2029 $87.99 $36.45 40.58 2030 $96.67 $41.12 46.29 *Revenue and net income reported in billions How Eli Lilly’s Next 5 Years Could Play Out We expect Eli Lilly’s P/E ratio in 2025 to be 60 with an EPS of $19.11, resulting in a price target of $1140.00 This prediction is based on strong revenue growth of 18.37% to $52.80 billion and net income expansion to $17.29 billion, continuing the upward trajectory from previous years. For 2026, we anticipate a P/E ratio of 50 with an EPS of $25.03, leading to a price target of $1250.00. This reflects significant revenue growth of 18.37% to $62.50 billion and an increase in net income to $22.49 billion, driving higher earnings per share. Heading into 2027, we project the P/E ratio to remain at 50, with EPS increasing to $30.39. This results in a price target of $1520.00. Continued revenue growth of 13.39% to $70.87 billion and net income expansion to $27.12 billion justifies this substantial increase in stock price. With an EPS of $25.97 and a P/E ratio of 50 in 2028, we forecast the stock price to be $1300.00. A slight dip in EPS growth is expected, but sustained strong performance in net income to $32.20 billion and revenue growth of 13.84% to $80.68 billion keeps the stock highly valued. By 2029, we estimate Eli Lilly’s EPS to rise to $40.58, with the P/E ratio adjusting to 40. This gives us a price target of $1623.00. The continuous revenue growth of 9.06% to $87.99 billion and net income expansion to $36.45 billion supports this higher valuation. Eli Lilly Stocks Price Target for 2030 Price Target: $1850.00 Upside: 127.20% By 2030, we estimate Eli Lilly’s EPS to rise to $46.29, with the P/E ratio adjusting to 40. This gives us a price target of $1850.00. The continuous revenue growth of 9.86% to $96.67 billion and net income expansion to $41.12 billion supports this higher valuation. Year Price Target % Change From Current Price 2025 $1140.00 Upside of 10.01% 2026 $1250.00 Upside of 53.52% 2027 $1520.00 Upside of 86.67% 2028 $1300.00 Upside of 59.66% 2029 $1623.00 Upside of 99.32% 2030 $1850.00 Upside of 127.20% “The Next NVIDIA” Could Change Your Life If you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over. The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.” Click here to download your FREE copy. The post Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030 appeared first on 24/7 Wall St.. https://247wallst.com - 2 days ago
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows On Wednesday, Eli Lilly And Co LLY released detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), the longest completed study to date of tirzepatide. benzinga.com - 2 days ago
2 Top Growth Stocks to Buy on the Dip Their recent issues are nothing to fret over for investors focused on the long game. fool.com - 3 days ago
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years These are income stocks you can buy and hold forever. fool.com - 3 days ago
Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks SURMOUNT-1 results show a 94% reduction in risk of progression to type 2 diabetes across all pooled doses of tirzepatide compared to placebo over three years Results suggest one new case of diabetes could be prevented for every nine patients treated with tirzepatide Participants treated with tirzepatide had an average weight reduction of 22.9% (15 mg dose) INDIANAPOLIS , Nov. 13, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), the longest completed study to date of tirzepatide. Weekly tirzepatide (Zepbound® and Mounjaro®) injections (pooled 5 mg, 10 mg, 15 mg doses) significantly reduced the risk of progression to type 2 diabetes in adults with pre-diabetes and obesity or overweight, compared with placebo, over 176 weeks. prnewswire.com - 3 days ago
8. Profile Summary

Eli Lilly and Company LLY

image
COUNTRY US
INDUSTRY Drug Manufacturers - General
MARKET CAP $ 708 B
Dividend Yield 0.15%
Description Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Contact Lilly Corporate Center, Indianapolis, IN, 46285 https://www.lilly.com
IPO Date June 1, 1972
Employees 43000
Officers Mr. Jeffrey N. Simmons Senior Vice President & President of Elanco Animal Health Mr. Eric Dozier Executive Vice President of Human Resources & Diversity Mr. David A. Ricks Chairman, Chief Executive Officer & President Mr. Lucas E. Montarce Executive Vice President & Chief Financial Officer Mr. Alonzo Weems EVice President of Enterprise Risk Management and Chief Ethics & Compliance Officer Mr. Donald A. Zakrowski Senior Vice President of Finance & Chief Accounting Officer Mr. Diogo Rau EVice President & Chief Information and Digital Officer Dr. Daniel M. Skovronsky M.D., Ph.D. EVice President, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology Ms. Anat Hakim J.D. Executive Vice President, General Counsel & Secretary Mr. Jacob S. Van Naarden Executive Vice President & President of Loxo